Sex Differences in Neurobehavioral Response to THC
Sex Differences in Neurobehavioral Response to Acute THC in Adults With Cannabis Use Disorder
Medical University of South Carolina
40 participants
Apr 27, 2026
INTERVENTIONAL
Conditions
Summary
This study investigates sex differences in reward processing following acute THC administration in adults with cannabis use disorder (CUD). Using multimodal neuroimaging (MRS and fMRI), the study will assess glutamate levels in the nucleus accumbens and striatal BOLD response to monetary reward anticipation. Participants will complete two counterbalanced dosing sessions (oral THC 40 mg vs. placebo).
Eligibility
Inclusion Criteria7
- Age 21-45
- DSM-5 criteria for CUD
- Cannabis use ≥4 days/week
- THC-positive urine
- BMI 18-30
- Regular menstrual cycle (females)
- Willingness to use non-hormonal birth control (females)
Exclusion Criteria7
- Lifetime psychotic or bipolar disorder
- Recent drug use other than cannabis
- Current psychotropic medication
- Treatment-seeking for SUD
- Current psychiatric disorder (except mild alcohol, nicotine, or caffeine use disorder)
- Pregnancy/nursing
- MRI contraindications
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Oral dronabinol capsules (40 mg)
Matched placebo capsules
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07225777